top
Search terms
Results 1 - 7 of 7 - ordered by :
Epeuropace

Over time many stroke risk stratification schema have been developed, initially with the objective to better define high-risk patients who could be subjected to an inconvenient (and potentially ...

Europace, Editorial, Ron Pisters, Jonas B. Olesen, Gregory Y.H. Lip

Date : 01/01/2012 Item size : 140103 bytes
Epeuropace

Warfarin, the most commonly applied VKA, reduces the stroke risk by 64%.1 The major drawbacks of VKA therapy include the risk of bleeding, especially intracranial haemorrhage, many food and drugdrug ...

Europace, Review, T. Lewalter, P. Kanagaratnam, B. Schmidt, M. Rosenqvist, J. E. Nielsen-Kudsk, R. Ibrahim, B. A. Albers, A. J. Camm

Date : 01/05/2014
Epeuropace

The downside of anticoagulation is increased risk of major bleeding which amounts to 1% per year. [...]careful selection of patients for oral anticoagulation is required. Measurements of blood flow ...

Europace, Editorial, Freek W.A. Verheugt, Muchtiar Khan, Gijsbert S. De Ruiter, Robert K. Riezebos

Date : 01/07/2010
Escardio

Boris SCHMIDT (Frankfurt, DE) 14:00 P1180 Stroke reduction by combining catheter ablation and left atrial appendage closure in high risk patients Martin SWAANS (Nieuwegein, NL) 14:00 P1181 Does left ...

Poster session 5: Atrial fibrillation, drugs and tools

Date : 25/06/2013 Item size : 74599 bytes
Revistaespanola

A weak, grade IIb recommendation (ie, usefulness/efficacy less well established by evidence/opinion) was released by the 2012 European atrial fibrillation guidelines, reflecting uncertainty over ...

Revista Española de Cardiología

Date : 01/02/2013 Item size : 53714 bytes
ESC365

Risk of cardiovascular events with no antithrombotic therapy in patients with atrial fibrillation after left atrial appendage closure for stroke prevention in a multicenter analysis

Date : 28/08/2016